Intact skeletal muscle mitochondrial enzyme activity but diminished exercise capacity in advanced heart failure patients on optimal medical and device therapy

Clinical Research in Cardiology

Volumn 102, Issue 8, 2013, Pages 547-554

  Middlekauff, Holly R ^a   Verity, M Anthony ^a   Horwich, Tamara B ^a   Fonarow, Gregg C ^a   Hamilton, Michele A ^a   Shieh, Perry ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Exercise; Heart failure; Skeletal muscle; Sympathetic nerve activity

Indexed keywords

CLONIDINE; MITOCHONDRIAL ENZYME; PLACEBO;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME ACTIVITY; EXERCISE; FEMALE; HEART EXCITATION; HEART FAILURE; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; MALE; MORPHOMETRICS; NERVE CELL STIMULATION; SKELETAL MUSCLE; TREATMENT DURATION; VASTUS LATERALIS MUSCLE;

BIOPSY; CASE-CONTROL STUDIES; CLONIDINE; DOUBLE-BLIND METHOD; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; SYMPATHOLYTICS;

EID: 84880332608     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-013-0564-3     Document Type: Article

References (44)

1. Franciosa JA, Park M, Levine TB (1991) Lack of correlation between exercise capacity and indices of resting left ventricular performance in heart failure. Am J Cardiol 47:33-39
2. Higginbotham M, Morris KG, Conn EH et al (1983) Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol 51:51-52
3. Maskin CS, Forman R, Sonnenblick EH et al (1983) Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure. Am J Cardiol 51:177-182
4. Middlekauff HR (2010) Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 3:537-546
5. Harrington D, Anker SD, Chua TP et al (1997) Skeletal muscle function and its relation to exercise tolerance in chronic HF. J Am Coll Cardiol 30:1758-1764
6. Sullivan MJ, Green HJ, Cobb FR (1991) Altered skeletal muscle metabolic response to exercise in chronic heart failure. Circulation 84:1597-1607
7. Massie BM, Conway M, Rajagopalan B et al (1988) Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure: evidence for abnormalities unrelated to blood flow. Circulation 78:320-326
8. Poole-Wilson PA, Ferro R (1996) Role of skeletal muscle in the syndrome of chronic heart failure. J Mol Cell Cardiol 28:2275-2285
9. Mancini DM, Coyle E, Coggan A et al (1989) Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 80:1338-1346
10. Espoisto F, Mathieu-Costello O, Shabetai R, Wagner PD, Richardson RS (2010) Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors. J Am Coll Cardiol 55:1945-1954
11. Lunde PK, Sjaastad I, Schiotz Thorud HM et al (2001) Skeletal muscle disorders in heart failure. Acta Physiol Scand 171:277-294
12. Drexler H, Riede U, Munzel T et al (1992) Alterations of skeletal muscle in chronic heart failure. Circulation 85:1751-1759
13. Sullivan MJ, Green HJ, Cobb FR (1990) Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 81:518-527
14. Rehn TA, Munkvik M, Lunde PK et al (2012) Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease specific myopathy or a result of deconditioning? Heart Fail Rev 17:421-436
15. Vescovo G, Serfini F, Facchin LL (1996) Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. Heart 76:337-343
16. Duscha BD, Annex BH, Green HJ et al (2002) Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure. J Am Coll Cardiol 39:1170-1174
17. Gielen S, Adams V, Möbius-Winkler S et al (2003) Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 42:861-868
18. Mettauer B, Zoll J, Sanchez H et al (2001) Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. J Am Coll Cardiol 38:947-954
19. Negrao CE, Rondon MUPB, Tinucci T, Alves MJNA, Roveda F, Braga AMW, Reis SF, Nastari L, Barretto ACP, Krieger EM, Middlekauff HR (2001) Abnormal neurovascular control during exercise is linked to heart failure severity. Am J Physiol Heart 280:H1286-H1292
20. Coates AJ, Clark AL, Piepoli M, Volterrani M, Poole-Wilson PA (1994) Symptoms and quality of life in heart failure: the muscle hypothesis. Brit Heart J 72(Suppl):S36-S39
21. Muller-Wedan U, Wedan K (2000) Immune modulation by catecholamines- a potential mechanism of cytokine release in HF? Herz 25:271-273
22. Grassi G, Turri C, Seravalle G et al (2001) Effects of chronic clonidine administration on sympathetic nerve traffic and baroreflex function in heart failure. Hypertension 38:286-291
23. Middlekauff HR, Vigna C, Verity MA et al (2012) Abnormalities of calcium handling proteins in skeletal muscle mirror those of the heart in humans with heart failure: a shared mechanism? J Card Fail 9:724-733
24. Verity MA, Turnbull DM (1993) Assay of acyl-CoA dehydrogenase activity in frozen muscle biopsies: application to medium-chained acyl-CoA dehydrogenase deficiency. Biochem Med Metab Biol 49:351-362
25. Fischer JC, Ruitenbeek W, Trijbels JM et al (1986) Estimation of NADH oxidation in human skeletal muscle mitochondria. Clin Chim Acta 155:263-273
26. Sottocasa GL, Kuylenstierna B, Ernster L et al (1967) An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J Cell Biol 32:415-438
27. Cooperstein SJ, Lazarow A (1951) A microspectrophotometric method for the determination of the cytochrome oxidase. J Biol Chem 189:665-670
28. Srere PA, Kosicki GW (1961) The purification of citrate-condensing enzyme. J Biol Chem 236:2557-2559
29. Dubowitz V, Sewry CA (2006) Muscle biopsy: a practical approach, 3rd edn. Saunders, Philadelphia
30. Charles-Schoeman S, Verity MA (2012) Nicotinamide adenine dinucleotide tetrazolium reductase identifies microvasculature activation in muscle from adult patients with dermatomyositis. J Rheum 39:94-99
31. Wallin BG, Fagius J (1988) Peripheral sympathetic neural activity in conscious humans. Ann Rev Physiol 50:565-576
32. Delius W, Hagbarth KE et al (1972) General characteristics of sympathetic activity in human muscle nerves. Acta Physiol Scand 84:65-81
33. Park J, Middlekauff HR (2009) Altered pattern of sympathetic activity with the ovarian cycle in female smokers. Am J Physiol Heart Circ Physiol 297:H564-H568
34. Tyni-Lenné R, Gordon A, Europe E et al (1998) Exercise-based rehabilitation improves skeletal muscle capacity, exercise tolerance, and quality of life in both women and men with chronic heart failure. J Card Fail 4:9-17
35. Ingjer F (1979) Effects of endurance training on muscle fibre type ATPase activity, capillary supply and mitochondrial content in man. J Physiol 294:419-432
36. Brooke MH, Engel WK (1969) The histographic analysis of human muscle biopsies with regard to fiber types: adult male and female. Neurology 19:221-233
37. Vescovo G, Dalla Libera L, Serafini F et al (1998) Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition. Circulation 98:1742-1749
38. Dalla Libera L, Ravara B, Gobbo V et al (2005) Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of carvedilol. J Molec Cell Cardiol 38:803-807
39. Zoll J, Monassier L, Garnier A et al (2006) ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction. J Appl Physiol 101:385-391
40. Toth MJ, Miller MS, Ward KA et al (2012) Skeletal muscle mitochondrial density, gene expression and enzyme activities in human heart failure: minimal effects of the disease and resistance training. J Appl Physiol 112:1864-1874
41. Sterns DA, Ettinger SM, Gray KS et al (1991) Skeletal muscle metaboreceptor exercise responses are attenuated in heart failure. Circulation 84:2034-2039
42. Hasenfuss G (1998) Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 37:279-289
43. Bers DM (2001) Excitation-contraction coupling and cardiac contractile force, 2nd edn. Kluwer Academic Publishers, Dordrecht
44. Whellan DJ, Nigam A, Arnold M et al (2011) Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology - findings from the heart failure and a controlled trial investigating outcomes of exercise training study. Am Heart J 162:1003-1010